Cargando…
Circulating Levels of Osteopontin Predict Patients’ Outcome after Resection of Colorectal Liver Metastases
For colorectal liver metastases (CRLM), surgical resection is the only potentially curative therapy, but even successfully resected patients often face disease recurrence, leading to 5-year survival rate below 50%. Despite available preoperative stratification strategies, it is not fully elucidated...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6262509/ https://www.ncbi.nlm.nih.gov/pubmed/30373147 http://dx.doi.org/10.3390/jcm7110390 |
_version_ | 1783375121888575488 |
---|---|
author | Loosen, Sven H. Heise, Daniel Dejong, Cees H. Roy, Sanchari Tacke, Frank Trautwein, Christian Roderburg, Christoph Luedde, Tom Neumann, Ulf P. Binnebösel, Marcel |
author_facet | Loosen, Sven H. Heise, Daniel Dejong, Cees H. Roy, Sanchari Tacke, Frank Trautwein, Christian Roderburg, Christoph Luedde, Tom Neumann, Ulf P. Binnebösel, Marcel |
author_sort | Loosen, Sven H. |
collection | PubMed |
description | For colorectal liver metastases (CRLM), surgical resection is the only potentially curative therapy, but even successfully resected patients often face disease recurrence, leading to 5-year survival rate below 50%. Despite available preoperative stratification strategies, it is not fully elucidated which patients actually benefit from CRLM resection. Here we evaluated osteopontin, a secreted glyco-phosphoprotein, as a biomarker in the context of CRLM resection. Tissue levels of osteopontin were analysed in CRLM using reverse transcription polymerase chain reaction (RT-PCR) and immunohistochemistry. Pre- and postoperative osteopontin serum concentrations were analysed by enzyme-linked immunosorbent assay (ELISA) in 125 patients undergoing resection of CRLM as well as 65 healthy controls. Correlating with an upregulation of osteopontin tissue expression in CRLM, osteopontin serum levels were significantly elevated in patients with CRLM compared to healthy controls. Importantly, high pre- and post-operative osteopontin serum levels were associated with a poor prognosis after tumour resection. Patients with initial osteopontin serum levels above our ideal cut-off value of 264.4 ng/mL showed a significantly impaired median overall survival of 304 days compared to 1394 days for patients with low osteopontin levels. Together, our data suggest a role of osteopontin as a prognostic biomarker in patients with resectable CRLM that might help to identify patients who particularly benefit from liver resection. |
format | Online Article Text |
id | pubmed-6262509 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-62625092018-12-03 Circulating Levels of Osteopontin Predict Patients’ Outcome after Resection of Colorectal Liver Metastases Loosen, Sven H. Heise, Daniel Dejong, Cees H. Roy, Sanchari Tacke, Frank Trautwein, Christian Roderburg, Christoph Luedde, Tom Neumann, Ulf P. Binnebösel, Marcel J Clin Med Article For colorectal liver metastases (CRLM), surgical resection is the only potentially curative therapy, but even successfully resected patients often face disease recurrence, leading to 5-year survival rate below 50%. Despite available preoperative stratification strategies, it is not fully elucidated which patients actually benefit from CRLM resection. Here we evaluated osteopontin, a secreted glyco-phosphoprotein, as a biomarker in the context of CRLM resection. Tissue levels of osteopontin were analysed in CRLM using reverse transcription polymerase chain reaction (RT-PCR) and immunohistochemistry. Pre- and postoperative osteopontin serum concentrations were analysed by enzyme-linked immunosorbent assay (ELISA) in 125 patients undergoing resection of CRLM as well as 65 healthy controls. Correlating with an upregulation of osteopontin tissue expression in CRLM, osteopontin serum levels were significantly elevated in patients with CRLM compared to healthy controls. Importantly, high pre- and post-operative osteopontin serum levels were associated with a poor prognosis after tumour resection. Patients with initial osteopontin serum levels above our ideal cut-off value of 264.4 ng/mL showed a significantly impaired median overall survival of 304 days compared to 1394 days for patients with low osteopontin levels. Together, our data suggest a role of osteopontin as a prognostic biomarker in patients with resectable CRLM that might help to identify patients who particularly benefit from liver resection. MDPI 2018-10-26 /pmc/articles/PMC6262509/ /pubmed/30373147 http://dx.doi.org/10.3390/jcm7110390 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Loosen, Sven H. Heise, Daniel Dejong, Cees H. Roy, Sanchari Tacke, Frank Trautwein, Christian Roderburg, Christoph Luedde, Tom Neumann, Ulf P. Binnebösel, Marcel Circulating Levels of Osteopontin Predict Patients’ Outcome after Resection of Colorectal Liver Metastases |
title | Circulating Levels of Osteopontin Predict Patients’ Outcome after Resection of Colorectal Liver Metastases |
title_full | Circulating Levels of Osteopontin Predict Patients’ Outcome after Resection of Colorectal Liver Metastases |
title_fullStr | Circulating Levels of Osteopontin Predict Patients’ Outcome after Resection of Colorectal Liver Metastases |
title_full_unstemmed | Circulating Levels of Osteopontin Predict Patients’ Outcome after Resection of Colorectal Liver Metastases |
title_short | Circulating Levels of Osteopontin Predict Patients’ Outcome after Resection of Colorectal Liver Metastases |
title_sort | circulating levels of osteopontin predict patients’ outcome after resection of colorectal liver metastases |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6262509/ https://www.ncbi.nlm.nih.gov/pubmed/30373147 http://dx.doi.org/10.3390/jcm7110390 |
work_keys_str_mv | AT loosensvenh circulatinglevelsofosteopontinpredictpatientsoutcomeafterresectionofcolorectallivermetastases AT heisedaniel circulatinglevelsofosteopontinpredictpatientsoutcomeafterresectionofcolorectallivermetastases AT dejongceesh circulatinglevelsofosteopontinpredictpatientsoutcomeafterresectionofcolorectallivermetastases AT roysanchari circulatinglevelsofosteopontinpredictpatientsoutcomeafterresectionofcolorectallivermetastases AT tackefrank circulatinglevelsofosteopontinpredictpatientsoutcomeafterresectionofcolorectallivermetastases AT trautweinchristian circulatinglevelsofosteopontinpredictpatientsoutcomeafterresectionofcolorectallivermetastases AT roderburgchristoph circulatinglevelsofosteopontinpredictpatientsoutcomeafterresectionofcolorectallivermetastases AT lueddetom circulatinglevelsofosteopontinpredictpatientsoutcomeafterresectionofcolorectallivermetastases AT neumannulfp circulatinglevelsofosteopontinpredictpatientsoutcomeafterresectionofcolorectallivermetastases AT binneboselmarcel circulatinglevelsofosteopontinpredictpatientsoutcomeafterresectionofcolorectallivermetastases |